SEC Filing Summary: SIGA Technologies, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on January 16, 2015, by SIGA Technologies, Inc., a Delaware corporation. The report addresses a significant legal development involving a judgment against the company by PharmAthene, Inc.
Key Financial Metrics
The filing does not provide standard operating metrics such as revenue, profit, cash flow, or margins. The primary financial data disclosed relates to a legal judgment:
- Base Judgment Amount: $113,116,985 (awarded as expectation damages).
- Total Judgment Amount: $194,649,041.74 (includes prejudgment interest, costs, and fees).
- Debt and Liquidity: The filing text does not provide current debt levels or liquidity positions.
Material Changes
On January 15, 2015, the Delaware Court of Chancery entered a final judgment awarding PharmAthene, Inc. the total sum of $194,649,041.74. This represents a material contingent liability that has now become a confirmed judgment pending appeal.
Outlook, Risks, and Management Commentary
On January 16, 2015, SIGA filed a notice of appeal regarding the Court of Chancery's judgment. Management states it believes it has strong grounds for the appeal. However, the company explicitly notes that no assurance can be given that the appeal will be successful. The outcome of this appeal is a significant risk factor for the company's financial stability.
Key Facts for Investor Verification
- Verify the total liability exposure of $194,649,041.74 and its impact on the company's current cash reserves.
- Monitor the status of the appeal filed with the Delaware Court of Chancery.
- Review subsequent filings for any updates on the company's liquidity position given the magnitude of the judgment.
- Confirm whether the company has secured any financing to cover the potential payout if the appeal fails.